KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Assets (2016 - 2025)

Rigel Pharmaceuticals has reported Return on Assets over the past 15 years, most recently at 0.97% for Q4 2025.

  • Quarterly results put Return on Assets at 0.97% for Q4 2025, up 86.0% from a year ago — trailing twelve months through Dec 2025 was 0.97% (up 86.0% YoY), and the annual figure for FY2025 was 1.08%, up 96.0%.
  • Return on Assets for Q4 2025 was 0.97% at Rigel Pharmaceuticals, up from 0.5% in the prior quarter.
  • Over the last five years, Return on Assets for RIGL hit a ceiling of 0.97% in Q4 2025 and a floor of 0.68% in Q3 2022.
  • Median Return on Assets over the past 5 years was 0.11% (2024), compared with a mean of 0.08%.
  • Biggest five-year swings in Return on Assets: plummeted -60bps in 2022 and later surged 86bps in 2025.
  • Rigel Pharmaceuticals' Return on Assets stood at 0.1% in 2021, then crashed by -363bps to 0.47% in 2022, then surged by 54bps to 0.22% in 2023, then surged by 153bps to 0.12% in 2024, then skyrocketed by 742bps to 0.97% in 2025.
  • The last three reported values for Return on Assets were 0.97% (Q4 2025), 0.5% (Q3 2025), and 0.51% (Q2 2025) per Business Quant data.